{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:58:01Z","timestamp":1788818281574,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Allergy and Infectious Diseases"},{"name":"R01A171223"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.vaccine.2012.09.026","type":"journal-article","created":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T19:36:45Z","timestamp":1348169805000},"page":"6753-6758","source":"Crossref","is-referenced-by-count":31,"title":["Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni"],"prefix":"10.1016","volume":"30","author":[{"given":"Workineh","family":"Torben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loc","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souvik","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal A.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.09.026_bib0005","doi-asserted-by":"crossref","first-page":"353768","DOI":"10.1155\/2012\/353768","article-title":"Enhancing schistosomiasis control strategy for Zimbabwe: building on past experiences","volume":"2012","author":"Chimbari","year":"2012","journal-title":"J Parasitol Res"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2012.09.026_bib0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.idc.2012.03.004","article-title":"Schistosomiasis","volume":"26","author":"Gryseels","year":"2012","journal-title":"Infect Dis Clin North Am"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.09.026_bib0015","doi-asserted-by":"crossref","first-page":"e1694","DOI":"10.1371\/journal.pntd.0001694","article-title":"Combined spatial prediction of schistosomiasis and soil-transmitted helminthiasis in sierra leone: a tool for integrated disease control","volume":"6","author":"Hodges","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2012.09.026_bib0020","article-title":"Time to set the agenda for schistosomiasis elimination","volume":"May 10","author":"Rollinson","year":"2012","journal-title":"Acta Trop"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2012.09.026_bib0025","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1377\/hlthaff.28.6.1726","article-title":"Neglected tropical diseases: moving beyond mass drug treatment to understanding the science","volume":"28","author":"Mahmoud","year":"2009","journal-title":"Health Aff (Millwood)"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.09.026_bib0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-065X.2010.00976.x","article-title":"Vaccines to combat the neglected tropical diseases","volume":"239","author":"Bethony","year":"2011","journal-title":"Immunol Rev"},{"issue":"December (8)","key":"10.1016\/j.vaccine.2012.09.026_bib0035","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1517\/14712598.3.8.1271","article-title":"Schistosomiasis vaccines","volume":"3","author":"Hagan","year":"2003","journal-title":"Expert Opin Biol Ther"},{"issue":"August (6)","key":"10.1016\/j.vaccine.2012.09.026_bib0040","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1586\/14760584.7.6.745","article-title":"Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis","volume":"7","author":"Hotez","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2012.09.026_bib0045","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.biologicals.2009.02.008","article-title":"Neglected tropical disease vaccines","volume":"37","author":"Hotez","year":"2009","journal-title":"Biologicals"},{"issue":"April (5)","key":"10.1016\/j.vaccine.2012.09.026_bib0050","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00436-008-0887-6","article-title":"Experimental vaccines in animal models for schistosomiasis","volume":"102","author":"Siddiqui","year":"2008","journal-title":"Parasitol Res"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.09.026_bib0055","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4161\/hv.7.11.17017","article-title":"Schistosomiasis vaccines","volume":"7","author":"Siddiqui","year":"2011","journal-title":"Hum Vaccin"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2012.09.026_bib0060","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00436-009-1646-z","article-title":"Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine","volume":"105","author":"Ahmad","year":"2009","journal-title":"Parasitol Res"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.09.026_bib0065","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-3024.2008.01091.x","article-title":"Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni","volume":"31","author":"Ahmad","year":"2009","journal-title":"Parasite Immunol"},{"issue":"May (21)","key":"10.1016\/j.vaccine.2012.09.026_bib0070","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/j.vaccine.2009.02.096","article-title":"Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model","volume":"27","author":"Ahmad","year":"2009","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.09.026_bib0075","doi-asserted-by":"crossref","first-page":"e781","DOI":"10.1016\/j.ijid.2010.02.2266","article-title":"Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice","volume":"14","author":"Ahmad","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2012.09.026_bib0080","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/infdis\/jir545","article-title":"Preclinical Prophylactic Efficacy Testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic","volume":"204","author":"Ahmad","year":"2011","journal-title":"J Infect Dis"},{"issue":"October (15)","key":"10.1016\/j.vaccine.2012.09.026_bib0085","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0264-410X(97)00081-9","article-title":"Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain","volume":"15","author":"Hota-Mitchell","year":"1997","journal-title":"Vaccine"},{"issue":"March (11\u201312)","key":"10.1016\/j.vaccine.2012.09.026_bib0090","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0264-410X(98)00391-0","article-title":"Recombinant vaccinia viruses and gene gun vectors expressing the large subunit of Schistosoma mansoni calpain used in a murine immunization-challenge model","volume":"17","author":"Hota-Mitchell","year":"1999","journal-title":"Vaccine"},{"issue":"June (21\u201322)","key":"10.1016\/j.vaccine.2012.09.026_bib0095","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/S0264-410X(03)00159-2","article-title":"Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation","volume":"21","author":"Siddiqui","year":"2003","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.09.026_bib0100","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1128\/IAI.71.7.3844-3851.2003","article-title":"Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4","volume":"71","author":"Siddiqui","year":"2003","journal-title":"Infect Immun"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2012.09.026_bib0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1051\/parasite\/2005121003","article-title":"Characterization of protective immunity induced against Schistosoma mansoni via DNA priming with the large subunit of calpain (Sm-p80) in the presence of genetic adjuvants","volume":"12","author":"Siddiqui","year":"2005","journal-title":"Parasite"},{"issue":"February (12)","key":"10.1016\/j.vaccine.2012.09.026_bib0110","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.vaccine.2004.09.018","article-title":"Characterization of the immune response to DNA vaccination strategies for schistosomiasis candidate antigen, Sm-p80 in the baboon","volume":"23","author":"Siddiqui","year":"2005","journal-title":"Vaccine"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2012.09.026_bib0115","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1086\/651147","article-title":"Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine","volume":"201","author":"Zhang","year":"2010","journal-title":"J Infect Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.09.026_bib0120","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-3024.2009.01181.x","article-title":"Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse","volume":"32","author":"Zhang","year":"2010","journal-title":"Parasite Immunol"},{"issue":"May (2)","key":"10.1016\/j.vaccine.2012.09.026_bib0125","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.actatropica.2011.01.010","article-title":"Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum)","volume":"118","author":"Zhang","year":"2011","journal-title":"Acta Trop"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2012.09.026_bib0130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-3024.1986.tb00866.x","article-title":"Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivo","volume":"8","author":"Pearce","year":"1986","journal-title":"Parasite Immunol"},{"issue":"July (7\u20138)","key":"10.1016\/j.vaccine.2012.09.026_bib0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-3024.2005.00764.x","article-title":"Immunity induced by the radiation-attenuated schistosome vaccine","volume":"27","author":"Hewitson","year":"2005","journal-title":"Parasite Immunol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2012.09.026_bib0140","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.4049\/jimmunol.148.6.1792","article-title":"IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages","volume":"148","author":"Gazzinelli","year":"1992","journal-title":"J Immunol"},{"issue":"January (5)","key":"10.1016\/j.vaccine.2012.09.026_bib0145","first-page":"666","article-title":"Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis","volume":"27","author":"El","year":"2009","journal-title":"Vaccine"},{"issue":"December (2)","key":"10.1016\/j.vaccine.2012.09.026_bib0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0008-8749(82)90025-9","article-title":"Antibody-dependent murine macrophage-mediated damage to Schistosoma mansoni schistosomula in vitro","volume":"74","author":"Chung","year":"1982","journal-title":"Cell Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.09.026_bib0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4269\/ajtmh.1975.24.74","article-title":"Immune response of guinea pigs to Schistosoma mansoni. I. In vitro effects of antibody and neutrophils, eosinophils and macrophages on schistosomula","volume":"24","author":"Dean","year":"1975","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2012.09.026_bib0160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0035-9203(77)90036-0","article-title":"Morphological evidence for the ability of eosinophils to damage antibody-coated schistosomula","volume":"71","author":"Glauert","year":"1977","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.09.026_bib0165","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.128.4.1535","article-title":"Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection","volume":"128","author":"James","year":"1982","journal-title":"J Immunol"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2012.09.026_bib0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0014-4894(74)90005-8","article-title":"Schistosoma mansoni: simplified method for the production of schistosomules","volume":"35","author":"Colley","year":"1974","journal-title":"Exp Parasitol"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2012.09.026_bib0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-4894(82)90090-X","article-title":"Schistosoma mansoni: rapid isolation and purification of schistosomula of different developmental stages by centrifugation on discontinuous density gradients of Percoll","volume":"53","author":"Lazdins","year":"1982","journal-title":"Exp Parasitol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.09.026_bib0180","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1165\/ajrcmb\/8.4.384","article-title":"Isolation and partial characterization of subpopulations of alveolar macrophages, granulocytes, and highly enriched interstitial macrophages from rat lung","volume":"8","author":"Lavnikova","year":"1993","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2012.09.026_bib0185","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1038\/nprot.2006.435","article-title":"Isolation of CD4+ T cells from murine lungs: a method to analyze ongoing immune responses in the lung","volume":"1","author":"Sauer","year":"2006","journal-title":"Nat Protoc"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.09.026_bib0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jlb.55.2.141","article-title":"Functional characterization of interstitial macrophages and subpopulations of alveolar macrophages from rat lung","volume":"55","author":"Prokhorova","year":"1994","journal-title":"J Leukoc Biol"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2012.09.026_bib0195","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.vaccine.2011.01.040","article-title":"Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models","volume":"29","author":"Torben","year":"2011","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.09.026_bib0200","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<799::AID-IMMU799>3.0.CO;2-1","article-title":"Selectin and Lewis(x) are required as co-receptors in antibody-dependent cell-mediated cytotoxicity of human eosinophils to Schistosoma mansoni schistosomula","volume":"29","author":"Nutten","year":"1999","journal-title":"Eur J Immunol"},{"issue":"October (Suppl 1)","key":"10.1016\/j.vaccine.2012.09.026_bib0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000237716","article-title":"Comparative studies on schistosomulicidal activity of mouse and rat eosinophils","volume":"114","author":"Mahakunkijcharoen","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2012.09.026_bib0210","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4049\/jimmunol.159.2.804","article-title":"Role of adhesion molecules of the selectin-carbohydrate families in antibody-dependent cell-mediated cytotoxicity to schistosome targets","volume":"159","author":"Trottein","year":"1997","journal-title":"J Immunol"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2012.09.026_bib0215","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-3024.1992.tb00033.x","article-title":"Effects of recombinant tumour necrosis factor on antibody-dependent eosinophil-mediated damage to Schistosoma japonicum larvae","volume":"14","author":"Janecharut","year":"1992","journal-title":"Parasite Immunol"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2012.09.026_bib0220","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0035-9203(91)90231-M","article-title":"Eosinophilia and eosinophil helminthotoxicity in patients treated for Schistosoma mansoni infections","volume":"85","author":"Kimani","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2012.09.026_bib0225","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.4049\/jimmunol.144.10.4030","article-title":"Antibody-dependent killing of Schistosoma mansoni schistosomula in vitro by starch-elicited murine macrophages. Critical role of the cell surface integrin Mac-1 in killing mediated by the anti-Mr 16,000 mAb B3A","volume":"144","author":"Vignali","year":"1990","journal-title":"J Immunol"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2012.09.026_bib0230","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-3024.1990.tb00957.x","article-title":"Suppression of macrophage-mediated antibody-dependent killing of Schistosoma mansoni larvae by concanavalin A stimulated spleen cell-derived factor(s)","volume":"12","author":"Watanabe","year":"1990","journal-title":"Parasite Immunol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2012.09.026_bib0235","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1645\/GE-864R.1","article-title":"No overt cellular inflammation around intravascular schistosomes in vivo","volume":"92","author":"Keating","year":"2006","journal-title":"J Parasitol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.09.026_bib0240","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/IAI.65.1.219-226.1997","article-title":"Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni","volume":"65","author":"Ahmed","year":"1997","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.09.026_bib0245","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/IAI.69.1.386-391.2001","article-title":"Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum","volume":"69","author":"Zhang","year":"2001","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12013370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12013370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T22:05:21Z","timestamp":1687730721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12013370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":49,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0264410X12013370"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}